Study of Electrophysiological Markers of Antidepressants in Major Depressive Disorder

NANot yet recruitingINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

July 1, 2026

Study Completion Date

July 1, 2026

Conditions
Major Depressive Disorder
Interventions
DEVICE

Electroretinography (ERG)

ERG are specifically carried out for research. They are performed in Nancy with the MonPackOne device developed by Metrovision for participants at center n°1, and in Paris with the RETeval device developed by LKS Technologie for participants at center n°2. Both devices comply with ISCEV standard and are CE marked. They enable the reccord of Pattern ERG, Flash ERG and Multifocal ERG using corneal and skin electrodes, or Sensor Strip skin electrodes only, for the Nancy and Paris centers respectively.

Trial Locations (1)

54520

Centre Psychothérapique de Nancy, Laxou

All Listed Sponsors
lead

Centre Psychothérapique de Nancy

OTHER

NCT06532604 - Study of Electrophysiological Markers of Antidepressants in Major Depressive Disorder | Biotech Hunter | Biotech Hunter